Latest filing published 31 Jul 2019 for Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.).
No signal scores available.
Peter van der Velden appears in our data through filings on Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) shares, published by SEDI. The record holds 6 filings, for trades running from 7 June 2019 to 26 July 2019.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 31 July 2019 came the latest disclosure, a transaction in Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.). Between a trade and the moment it shows up on SEDI, the median delay is 13 days. That lag is the time during which only the insider knows about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations